Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry-Reference-Cited by-同舟云学术

Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry

Published:2020-12 Issue:12 Volume:26 Page:2252-2261
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Lwin Yadanar,Kennedy Glenn,Gottlieb David,Kwan John,Ritchie David,Szer Jeff,Milliken Samuel,Browett Peter,Spencer Andrew,Butler Andrew,Bardy Peter,Greenwood Matthew,Perera Travis,He Simon,McEwan Ashley,Larsen Stephen,Lai Hock,Purtill Duncan,Tran Steven,Aarons Donna,Hamad Nada

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference41 articles.

1. Myelofibrosis with myeloid metaplasia;Tefferi;N Engl J Med,2000

2. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments];Dupriez;Blood,1996

3. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment;Cervantes;Blood,2009

4. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment);Passamonti;Blood,2010

5. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status;Gangat;J Clin Oncol,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplant Outcomes in Myelofibrosis: Impact of Donor Type [Cord Blood Grafts Supported by CD34+ selected Cells (Haplo-Cord) vs Matched Donors];Transplantation and Cellular Therapy;2024-09

2. Myelofibrosis and allogeneic transplantation: critical points and challenges;Frontiers in Oncology;2024-06-20

3. Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes;Frontiers in Oncology;2023-08-10

4. Impact of molecular profiling on the management of patients with myelofibrosis;Cancer Treatment Reviews;2022-09

5. Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis;American Journal of Hematology;2022-07-19